• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康焦虑和疫苗担忧是否能预测 COVID-19 疫苗接种后的自我报告不良事件?——一项丹麦全国队列研究。

Does health anxiety and vaccine concern predict self-reported adverse events following COVID-19 vaccination?-A Danish national cohort study.

机构信息

Department of Public Health, Aarhus University, DK-8000, Aarhus, Denmark.

Department of Public Health, Aarhus University, DK-8000, Aarhus, Denmark; Department of Quality and Patient Involvement, Aarhus University Hospital, DK-8200, Aarhus, Denmark.

出版信息

Public Health. 2024 Dec;237:299-306. doi: 10.1016/j.puhe.2024.10.007. Epub 2024 Oct 30.

DOI:10.1016/j.puhe.2024.10.007
PMID:39481186
Abstract

OBJECTIVES

The nocebo effect refers to an expectation of sickness that leads to sickness in the expectant. Studies have found COVID-19 vaccines to be associated with the nocebo effect. However, the literature in this field is sparse yet important with the continuation of booster vaccines.

STUDY DESIGN

National cohort study.

METHODS

This study used data from the Danish national cohort "BiCoVac", which contains self-reported information on both health anxiety and specific COVID-19 vaccine concern, as well as 19 systemic AEs following COVID-19 vaccination. Simple and multiple logistic regression was used to estimate the association between health anxiety and specific COVID-19 vaccine concern with having one or more systemic AEs following COVID-19 vaccination. Inverse probability weights were used to compensate for the initial dropout and loss to follow-up.

RESULTS

Of the 85,080 participants in the study, 4 % reported health anxiety, 30 % reported specific COVID-19 vaccine concern, and 26 % one or more systemic AEs following vaccination. After adjusting for covariates, participants with health anxiety had higher odds of reporting one or more systemic AEs following vaccination compared to those without (OR, 1·21 CI 95 % [1·10; 1·33]). For specific COVID-19 vaccine concern, the OR was 1·51 CI 95 % [1·45; 1·58].

CONCLUSIONS

Participants with specific COVID-19 vaccine concern had higher odds of reporting one or more systemic AEs following vaccination compared with those who had no specific COVID-19 vaccine concern. There might be a potential to reduce AEs, with positive framing of AEs and information about nocebo. Reporting of AEs was also associated with health anxiety, but to a lesser degree.

摘要

目的

反安慰剂效应是指对疾病的预期会导致预期中的疾病。研究发现 COVID-19 疫苗与反安慰剂效应有关。然而,随着加强疫苗的继续使用,该领域的文献仍然很重要,但还很匮乏。

研究设计

全国队列研究。

方法

本研究使用了丹麦全国队列“BiCoVac”的数据,该队列包含了对健康焦虑和特定 COVID-19 疫苗担忧的自我报告信息,以及 COVID-19 疫苗接种后 19 种全身不良事件。简单逻辑回归和多逻辑回归用于估计健康焦虑和特定 COVID-19 疫苗担忧与 COVID-19 疫苗接种后发生一种或多种全身不良事件之间的关联。逆概率权重用于补偿初始辍学和随访丢失。

结果

在研究的 85080 名参与者中,4%报告有健康焦虑,30%报告有特定 COVID-19 疫苗担忧,26%报告接种疫苗后有 1 种或多种全身不良事件。调整了协变量后,与无健康焦虑的参与者相比,有健康焦虑的参与者报告接种疫苗后发生一种或多种全身不良事件的几率更高(比值比,95%置信区间[1.10;1.33])。对于特定 COVID-19 疫苗担忧,比值比为 1.51,95%置信区间[1.45;1.58]。

结论

与没有特定 COVID-19 疫苗担忧的参与者相比,有特定 COVID-19 疫苗担忧的参与者报告接种疫苗后发生一种或多种全身不良事件的几率更高。通过积极描述不良事件和提供关于反安慰剂的信息,有可能减少不良事件。不良事件的报告也与健康焦虑有关,但程度较轻。

相似文献

1
Does health anxiety and vaccine concern predict self-reported adverse events following COVID-19 vaccination?-A Danish national cohort study.健康焦虑和疫苗担忧是否能预测 COVID-19 疫苗接种后的自我报告不良事件?——一项丹麦全国队列研究。
Public Health. 2024 Dec;237:299-306. doi: 10.1016/j.puhe.2024.10.007. Epub 2024 Oct 30.
2
Sex and gender differences in adverse events following influenza and COVID-19 vaccination.流感和 COVID-19 疫苗接种后不良事件的性别差异。
Biol Sex Differ. 2024 Jun 18;15(1):50. doi: 10.1186/s13293-024-00625-z.
3
Prevalence of and risk factors for self-reported menstrual changes following COVID-19 vaccination: a Danish cohort study.新冠病毒疫苗接种后自我报告的月经变化的患病率及危险因素:一项丹麦队列研究
Hum Reprod. 2023 Sep 5;38(9):1825-1834. doi: 10.1093/humrep/dead144.
4
Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis.COVID-19 疫苗试验安慰剂组不良事件的频率:系统评价和荟萃分析。
JAMA Netw Open. 2022 Jan 4;5(1):e2143955. doi: 10.1001/jamanetworkopen.2021.43955.
5
COVID-19 vaccination in patients with primary immunodeficiencies: an international survey on patient vaccine hesitancy and self-reported adverse events.原发性免疫缺陷病患者的 COVID-19 疫苗接种:一项针对患者疫苗犹豫和自我报告不良事件的国际调查。
Front Immunol. 2023 Apr 18;14:1166198. doi: 10.3389/fimmu.2023.1166198. eCollection 2023.
6
Cohort profile: The BiCoVac cohort - a nationwide Danish cohort to assess short and long-term symptoms following COVID-19 vaccination.队列简介:BiCoVac队列——一个丹麦全国性队列,用于评估新冠病毒疫苗接种后的短期和长期症状。
Eur J Epidemiol. 2025 Feb;40(2):225-233. doi: 10.1007/s10654-025-01204-1. Epub 2025 Feb 7.
7
Reported Adverse Events and Associated Factors in Korean Coronavirus Disease 2019 Vaccinations.韩国 2019 冠状病毒病疫苗接种的不良事件报告和相关因素。
J Korean Med Sci. 2024 Nov 4;39(42):e274. doi: 10.3346/jkms.2024.39.e274.
8
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study.COVID-19 疫苗安全性和与易受暗示相关的系统性风湿病患者犹豫:一项横断面研究。
Rheumatol Int. 2022 Jan;42(1):31-39. doi: 10.1007/s00296-021-05039-3. Epub 2021 Nov 5.
9
The descriptive epidemiology of adverse events following two doses of mRNA COVID-19 vaccination in Curaçao, the Caribbean.加勒比地区库拉索岛两剂mRNA新冠疫苗接种后不良事件的描述性流行病学
Infect Dis (Lond). 2025 Feb;57(2):137-149. doi: 10.1080/23744235.2024.2399108. Epub 2024 Sep 3.
10
Pattern of self-reported adverse events related to COVID-19 vaccines in Saudi Arabia: A nationwide study.沙特阿拉伯与 COVID-19 疫苗相关的不良事件自我报告模式:一项全国性研究。
Front Public Health. 2023 Feb 23;11:1043696. doi: 10.3389/fpubh.2023.1043696. eCollection 2023.

引用本文的文献

1
Cohort profile: The BiCoVac cohort - a nationwide Danish cohort to assess short and long-term symptoms following COVID-19 vaccination.队列简介:BiCoVac队列——一个丹麦全国性队列,用于评估新冠病毒疫苗接种后的短期和长期症状。
Eur J Epidemiol. 2025 Feb;40(2):225-233. doi: 10.1007/s10654-025-01204-1. Epub 2025 Feb 7.